Feasibility of the Radio-Frequency Microstimulator System to Improve Arm Function Following Traumatic Brain Injury

Traumatic brain injury (TBI) could involve damage to motor pathways within the central
nervous system, resulting in loss of arm function from symptoms including general weakness,
loss of power, motor control abnormalities and spasticity.

The Radiofrequency Microstimulator (RFM) System consists of fully implanted, leadless
stimulators that are injected in a minimally invasive procedure. RFMs measure 16.7mm long,
2.4mm dia. and can be placed directly at target nerves in the arm to drive specific muscle
contractions. This system has demonstrated efficacy in arm rehabilitation for stroke
patients who suffer from loss of arm function similar to that experienced by some TBI
patients.

This feasibility study will evaluate if the RFM system can be used to assist patients in the
rehabilitation of arm function following TBI. TBI patients that pass screening will have up
to 7 RFM devices implanted in their disabled arm. After implantation, patients will
participate in four phases of therapy, each lasting 12 weeks and consisting of standard
occupational therapy occurring at regular intervals at home and in the clinic. In the first
phase, therapy will not involve use of the RFM System. In the second phase, occupational
therapy will be assisted by electrical stimulation using the RFM System. The third and
fourth phases will repeat the therapies of the first and second phases, respectively. Arm
function following therapy with RFM stimulation will be compared to arm function after
therapy without RFM stimulation.

Inclusion Criteria:

1. Subject sustained a Traumatic Brain Injury at least 6 and no more than 48 months
prior to time of consenting.

2. As a result of Traumatic Brain Injury, subject has impaired hand function associated
with poor control and weakness of wrist and elbow extensors on at least one side.

3. Subject has some preserved control of the arm to be treated as demonstrated by any
voluntary movement of fingers and shoulder.

4. Subject has functional, passive Range of Motion at the shoulder, elbow, wrist and
finger joints of the arm to be treated.

5. Subject's spasticity has been maximally medically controlled and documented stable
without change in medication or therapies for a minimum of one month.

6. Peripheral neuromuscular system is intact as demonstrated by electrophysiologic
response to routine clinical nerve conduction studies and electromyography on the arm
to be treated.

7. Subject is assigned a level no less than VII on the Rancho Los Amigos Levels of
Cognitive Functioning Scale.

8. Subject is fluent in English.

9. Subject or their legally authorized representative has signed an informed consent
form.

10. Subject (either male or female) is at least 18 years of age at time of consent.

11. Subject is willing and capable of traveling to the investigational site for study
visits outlined in this protocol.

12. In the opinion of the Principal Investigator (PI), subject will be able to apply per
protocol therapy at home, with the aid of a caregiver if necessary.

Exclusion Criteria:

1. Subject is unwilling to perform all of the therapies and assessments required for the
study.

2. Subject has an active implant device (e.g. pacemaker, implanted cardiac
defibrillator, neurostimulator, or drug infusion device).

3. Subject has a metal implant (e.g. orthopedic hardware, stent, etc.) that is located
within 12 cm of where the RF Coil surface will be placed for the RFM E-Stim therapy.

4. Subject has metal fragments, metal implants, bullet fragments, metal chips or clips
in or around the orbits or cranium or any other metal inside the body that would
contraindicate an MRI or make it unreadable for the purpose of analysis.

5. Subject with a congenital defect, contracture, upper extremity trauma, or other
non-TBI condition that limits range of motion or neuromuscular function of the
involved arm.

6. Subject has a documented diagnosis of HIV or other life limiting infection or
disease.

7. A female subject who is pregnant, nursing, or planning to become pregnant during the
course of the study. Women of childbearing potential must maintain effective
contraception during the study period, as judged by the Investigator.

8. Subject has a major psychological disorder, such as poorly controlled schizophrenia
or paranoia, such that cooperative status is inconsistent.

9. Subject has severe claustrophobia, movement that cannot be medically controlled or
other condition that would limit their ability to undergo an MRI scan or remain still
throughout an MRI scan.

10. Subject has non-controlled epilepsy.

11. In the opinion of the PI, subject has a high level of residual spasticity despite
maximal medical therapy.

12. Subject has peripheral neuropathy or myopathy in either upper extremity that would
preclude implementation of proposed stimulation techniques (i.e. involvement of
peripheral nerves or muscles involved in extension of the elbow, wrist, or fingers).
An exception is made for carpel tunnel syndrome.

13. Subject has a muscle power grade of more than 3 on the elbow, wrist and finger
extensors of the arm to be treated, according to the Medical Research Council (MRC)
scale.

14. Subject has a history of endocarditis, a prosthetic valve or murmur.

15. Subject has a history of adverse reactions to anesthetic agents.

16. Recent or current participation in research that may influence response to either
study intervention, or be harmful to the subject in any way.

17. Subject's life expectancy is less than 1.5 years.

18. Subject has any bleeding or clotting disorder.

19. Subject has pain that in the opinion of the PI would impair participation.

20. Subject is unwilling to refrain from use of transcutaneous electrical stimulation on
the arm to be treated for the duration of their study participation.

21. The PI does not feel the subject is a suitable candidate for the study, for any
reason.